Novartis announces the appointment of Bruno Strigini as President of Novartis Oncology

Basel, June 1, 2014 - Novartis announced today the appointment of Bruno Strigini, as President of Novartis Oncology, effective June 1, 2014.

Mr. Strigini joins Novartis from Merck & Co where he most recently served as president for Europe/Canada, a region comprising 37 countries with over 10,000 associates. With 25 years of experience in pharmaceuticals, animal health, OTC and vaccines leading in both international and local roles, he has a global perspective on the healthcare industry, with expertise across diverse geographies, including both mature and emerging markets.

Novartis announces the appointment of Bruno Strigini as President of Novartis Oncology